Metabolic characteristics of acute necrotizing pancreatitis and chronic pancreatitis

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 57-62

  Ma, Chao ^a   Tian, Bing ^a   Wang, Jian ^a   Yang, Gen Jin ^b   Pan, Chun Shu ^a   Lu, Jian Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Magic angle spinning; Metabolic profiles; Nuclear magnetic resonance; Principal component analysis

Indexed keywords

BETAINE; CHOLINE; FATTY ACID; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; ISOLEUCINE; LACTIC ACID; LEUCINE; LIPID; PHOSPHORYLCHOLINE; TAURINE; VALINE;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; MALE; METABOLISM; METABOLITE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TISSUE LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PANCREATITIS, ACUTE NECROTIZING; PANCREATITIS, CHRONIC; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 84861602961     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.881     Document Type: Article

References (46)

1. Spanier BW, Dijkgraaf MG and Bruno MJ: Trends and forecasts of hospital admissions for acute and chronic pancreatitis in the Netherlands. Eur J Gasroenterol Hepatol 20: 653-658, 2008.
2. Mitchell RM, Byrne MF and Baillie J: Pancreatitis. Lancet 361: 1447-1455, 2003. (Pubitemid 36515050)
3. Braganza JM: Evolution of pancreatitis. In: The Pathogenesis of Pancreatitis. Braganza JM (ed.). Manchester University Press, Manchester, 1991.
4. Sarles H: Pancreatitis: Symposium of Marseille, 1963. Karger, Basel, 1965.
5. Varon TH and Morgan DE: Acute necrotizing pancreatitis. N Engl J Med 340: 1412-1417, 1999. (Pubitemid 29205406)
6. Bai Y, Liu Y, Jia L, et al: Severe acute pancreatitis in China: etiology and mortality in 1976 patients. Pancreas 35: 232-237, 2007. (Pubitemid 47482515)
7. Felderbauer P, Muller C, Bulut K, et al: Pathophysiology and treatment of acute pancreatitis: new therapeutic targets - a ray of hope? Basic Clin Pharmacol Toxicol 97: 342-350, 2005. (Pubitemid 43028780)
8. Raraty MG, Connor S, Criddle DN, Sutton R and Neoptolemos JP: Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 6: 99-103, 2004. (Pubitemid 38915055)
9. Etemad B and Whitcomb DC: Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120: 682-707, 2001. (Pubitemid 32171640)
10. Witt H, Apte MV, Keim V and Wilson JS: Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 132: 1557-1573, 2007. (Pubitemid 46627604)
11. Lowenfels AB, Maisonneuve P and Whitcomb DC: Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am 84: 565-573, 2000. (Pubitemid 30346152)
12. Talamini G, Falconi M, Bassi C, et al: Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol 94: 1253-1260, 1999. (Pubitemid 29214638)
13. Lowenfels AB, Maisonneuve P, Cavallini G, et al: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328: 1433-1437, 1993. (Pubitemid 23143844)
14. Wu BU: Prognosis in acute pancreatitis. CMAJ 183: 673-677, 2011.
15. Kamisawa T: Is it time to reconsider autoimmune pancreatitis? J Gastroenterol 41: 1240-1241, 2006.
16. Tsai MJ, Chen C, Chen SH, Huang YT and Chiu TH: Pomalidomide suppresses cerulein-induced acute pancreatitis in mice. J Gastroenterol 46: 822-833, 2011.
17. Strate L, Knoefel W, Yekebas E and Izbicki JR: Chronic pancreatitis: etiology, pathogenesis, diagnosis and treatment. Int J Colorectal Dis 18: 97-106, 2003.
18. Al-Haddad M and Eloubeidi MA: Diagnostic and therapeutic applications of endoscopic ultrasound-guided punctures. Dig Dis 26: 390-397, 2008.
19. DiMagno E, Layer P and Clain J: Chronic pancreatitis. In: The Pancreas: Biology, Pathophysiology and Disease. Raven, New York, 1993.
20. Bolog N, Constantinescu G, Oancea I, et al: Magnetic resonance imaging of bile and pancreatic ducts: a retrospective study. Rom J Gastroenterol 13: 91-97, 2004. (Pubitemid 38899343)
21. Cavestro GM, Zuppardo RA, Bertolini S, et al: Connections between genetics and clinical data: role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis. Am J Gastroenterol 105: 199-206, 2010.
22. Clain JE and Pearson RK: Diagnosis of chronic pancreatitis: is a gold standard necessary? Surg Clin North Am 79: 829-845, 1999. (Pubitemid 29383598)
23. Büchler MW, Martigone ME, Friess H and Malfertheiner P: A proposal for a new clinical classification of chronic pancreatitis. BMC Gastroenterol 9: 93-101, 2009.
24. Maartense S, Ledeboer M and Masclee AAM: Chronic pancreatitis: relation between function and morphology. Dig Liver Dis 36: 61-67, 2004. (Pubitemid 41122226)
25. Cohn JA: Reduced CFTR function and the pathobiology of idiopathic pancreatitis. J Clin Gastroenterol 39: S70-S77, 2005.
26. Wang J, Ma C, Liao Z, Tian B and Lu JP: Study on chronic pancreatitis and pancreatic cancer using MRS and pancreatic juice samples. World J Gastroenterol 17: 2126-2130, 2011.
27. Lesi C, Melzi D'Eril GV, Pavesi F, et al: Clinical significance of serum pancreatic enzymes in the quiescent phase of chronic pancreatitis. Clin Biochem 18: 235-238, 1985. (Pubitemid 16246432)
28. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC and Nicholson JK: Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2: 2692-2703, 2007.
29. Moestue S, Sitter B, Bathen TF, Tessem MB and Gibbestad IS: High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer. Prog Nucl Magn Reson Spectrosc 54: 239-254, 2009.
30. Lindon JC, Beckonert OP, Holmes E and Nicholson JK: High-resolution magic angle spinning NMR spectroscopy: application to biomedical studies. Prog Nucl Magn Reson Spectrosc 55: 79-100, 2009.
31. Fang F, He XH, Deng HW, Chen Q, Lu JP, Spraul M and Yu YH: Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis. Cancer Sci 98: 1678-1682, 2007. (Pubitemid 47487900)
32. Holmes E, Nicholls AW, Lindon JC, et al: Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem Res Toxicol 13: 471-478, 2000. (Pubitemid 30416342)
33. Merkord J, Weber H, Sparmann G, Jonas L and Hennighausen G: The course of pancreatic fibrosis induced by dibutyltin dichloride (DBTC). Ann NY Acad Sci 880: 231-237, 1999. (Pubitemid 29349131)
34. Dabrowska A, Jacewicz D, Lapinska A, et al: Pivotal participation of nitrogen dioxide in l-arginine induced acute necrotizing pancreatitis: protective role of superoxide scavenger 4-OH-TEMPO. Biochem Biophys Res Commun 326: 313-320, 2005. (Pubitemid 39593548)
35. Griffin JL, Mannb CJ, Scottc J, Shoulders CC and Nicholoson JK: Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes. FEBS Lett 509: 263-266, 2001. (Pubitemid 34015954)
36. Garrod S, Humpfer E, Spraul M, et al: High-resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn Reson Med 41: 1108-1118, 1999. (Pubitemid 29247278)
37. Cho SG, Lee DH, Lee KY, Ji H, Lee KH, Ros PR and Sun CH: Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr 29: 163-169, 2005. (Pubitemid 40411298)
38. Govindaraju V, Young K and Maudsley AA: Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13: 129-153, 2000. (Pubitemid 30414704)
39. Miller BL, Chang L, Booth R, et al: In vivo 1H MRS choline: correlation within vitro chemistry/histology. Life Sci 58: 1929-1935, 1996.
40. Tan J, Bluml S, Hoang T, Dubowitz D, Mevenkamp G and Ross B: Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Reson Med 39: S1005-S1010, 1998.
41. Cheng LL, Anthony DC, Comite AR, Black PM, Tzika AA and Gonzalez RG: Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro Oncol 2: 87-95, 2000.
42. Loening NM, Chamberlin AM, Zepeda AG, Gonzalez RG and Cheng LL: Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy. NMR Biomed 18: 413-420, 2005. (Pubitemid 41646182)
43. Barker PB, Breiter SN, Soher BJ, et al: Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 32: 157-163, 1994. (Pubitemid 24243294)
44. Hardy DL and Norwood TJ: Spectral editing techniques for the in vitro and in vivo detection of taurine. J Magn Reson 133: 70-78, 1998. (Pubitemid 128450612)
45. Kinoshita Y, Kajiwara H, Yokota A and Koga Y: Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35: 606-613, 1994.
46. Sitter B, Bathen TF, Hagen B and Gibbestad IS: Cervical cancer tissue characterized by high resolution magic angle spinning MR spectroscopy. MAGMA 16: 174-181, 2004. (Pubitemid 38657623)